Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-03

FDA Approved: OXCARBAZEPINE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the Original Application for Oxcarbazepine from Zydus Lifesciences Limited, providing a generic option for the treatment of epilepsy. This marks re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)